Zoetis Revenue 2024

Zoetis Revenue

9.28 B USD

Zoetis Dividend yield

0.89 %

Ticker

ZTS

ISIN

US98978V1035

WKN

A1KBYX

In 2024, Zoetis's sales reached 9.28 B USD, a 8.6% difference from the 8.54 B USD sales recorded in the previous year.

The Zoetis Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2030e13.9743,09
2029e12.4148,53
2028e11.8350,89
2027e11.3153,25
2026e10.5956,87
2025e9.9460,59
2024e9.2864,89
20238.5470,47
20228.0869,73
20217.7870,61
20206.6869,36
20196.2668,43
20185.8367,67
20175.3166,78
20164.8966,53
20154.7764,03
20144.7964,79
20134.5663,93
20124.3464,18
20114.2361,12
20103.5859,69
20092.7662,86

Zoetis Aktienanalyse

What does Zoetis do?

Zoetis Inc. is a leading company in the development and marketing of animal health technology and solutions. The company specializes in innovative products for animals such as dairy cattle, pigs, poultry, dogs, cats, and horses. Zoetis was founded in 1952 as a subsidiary of Pfizer and operated as Pfizer Animal Health. In 2013, the company was finally spun off from Pfizer and became Zoetis Inc. Zoetis focuses on the development, manufacturing, and marketing of products for livestock and pets, including vaccines, pharmaceuticals, biological therapies, and diagnostics. The company operates globally and has its headquarters in Parsippany, New Jersey. Zoetis' business model consists of various business segments divided into animal categories: cattle, pigs, poultry, pets, and horses. Each of these business segments offers specialized solutions for animal owners and veterinarians. In the cattle products segment, Zoetis offers products for dairy cows, beef cattle, and calves. They also provide a variety of prevention and treatment solutions for major animal health issues such as mastitis, reproductive disorders, and respiratory problems. In the swine segment, Zoetis offers prevention and treatment solutions for infectious diseases and parasite control. They also provide products for promoting swine health and weight gain. In the poultry segment, Zoetis offers solutions for the prevention and treatment of infectious diseases. The company's products aim to improve animal health, productivity, and efficiency. Zoetis also offers products for the pet segment, including vaccines, pharmaceuticals, and therapies for dogs, cats, and other pets. Here, the company also provides solutions for major health issues such as heart diseases, pain management, and parasite control. In the horse segment, Zoetis offers solutions for the prevention and treatment of diseases such as equine rhinopneumonia, worm infestations, and arthritis. They also provide products for promoting horse health and performance. Zoetis is known for a variety of innovative products used by animal owners and veterinarians worldwide. One example is ScourGuard® 4KC, a vaccine that protects calves from diarrheal diseases caused by common bacteria. This vaccine has already proven to be highly effective in controlling bowel diseases in calves. Zoetis has also developed and marketed the first FDA-approved product for pain management in dogs (Rimadyl®), as well as the first licensed product for the treatment of giardia in dogs (Panacur®). In summary, Zoetis, as a global leader in the animal health industry, puts innovation and quality at the forefront. With a wide range of products and solutions in various animal categories, Zoetis is a key player in the animal health industry. Zoetis ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Zoetis's Sales Figures

The sales figures of Zoetis originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Zoetis’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Zoetis's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Zoetis’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Zoetis Stock

How much revenue did Zoetis generate this year?

Zoetis has achieved a revenue of 9.28 B USD this year.

How much was the turnover of the company Zoetis compared to the previous year?

The revenue of Zoetis has increased by 8.6% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Zoetis?

The revenue of Zoetis is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Zoetis measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Zoetis so important for investors?

The revenue of Zoetis is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Zoetis pay?

Over the past 12 months, Zoetis paid a dividend of 1.5 USD . This corresponds to a dividend yield of about 0.89 %. For the coming 12 months, Zoetis is expected to pay a dividend of 2.03 USD.

What is the dividend yield of Zoetis?

The current dividend yield of Zoetis is 0.89 %.

When does Zoetis pay dividends?

Zoetis pays a quarterly dividend. This is distributed in the months of August, November, February, May.

How secure is the dividend of Zoetis?

Zoetis paid dividends every year for the past 18 years.

What is the dividend of Zoetis?

For the upcoming 12 months, dividends amounting to 2.03 USD are expected. This corresponds to a dividend yield of 1.2 %.

In which sector is Zoetis located?

Zoetis is assigned to the 'Health' sector.

Wann musste ich die Aktien von Zoetis kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Zoetis from 6/4/2024 amounting to 0.432 USD, you needed to have the stock in your portfolio before the ex-date on 4/18/2024.

When did Zoetis pay the last dividend?

The last dividend was paid out on 6/4/2024.

What was the dividend of Zoetis in the year 2023?

In the year 2023, Zoetis distributed 1.3 USD as dividends.

In which currency does Zoetis pay out the dividend?

The dividends of Zoetis are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Zoetis stock can be added to a savings plan with the following providers: Trade Republic and Consorsbank

Andere Kennzahlen von Zoetis

Our stock analysis for Zoetis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zoetis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.